Free. Unsubscribe any time.
Kiniksa Pharmaceuticals International, plc (KNSA)
Kiniksa Pharmaceuticals International, plc filed 61 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 97 transactions and 2,316,236 shares. None carries the SEC's AFF10B5ONE flag; all 61 name a plan in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-03, came 121 days after the one before it (2026-05-05) and reports 13 transactions against 4 in the filing before it.
- The sales it reports total 4,600 shares, 53,824 fewer than the 58,424 in the filing before it.
- Of the 10 companies the register lists beside it in its industry, 2 have more plan statements on file than it and 8 have fewer.
- Its 61 filings on file run from 2025-01-15 to 2026-09-03, and state no plan adoption date.
Trades in Kiniksa Pharmaceuticals International, plc 97
- Tessari Eben — 2025-01-13 · S · 12,323 shares
- Tessari Eben — 2025-01-13 · S · 1,677 shares
- Tessari Eben — 2025-02-10 · S · 14,000 shares
- Tessari Eben — 2025-03-10 · S · 12,409 shares
- Megna Michael R — 2025-03-12 · S · 9,051 shares
- Ragosa Mark — 2025-03-12 · S · 36,372 shares
- Ragosa Mark — 2025-03-17 · S · 11,464 shares
- Ragosa Mark — 2025-03-19 · S · 8,879 shares
- Ragosa Mark — 2025-03-20 · S · 15,944 shares
- Tessari Eben — 2025-04-14 · S · 5,579 shares
- Tessari Eben — 2025-04-14 · S · 6,421 shares
- Moat Ross — 2025-04-21 · S · 18,259 shares
Adoption dates in Kiniksa Pharmaceuticals International, plc 0
Results prints in Kiniksa Pharmaceuticals International, plc 9
- 2025-01-13
- 2025-02-25
- 2025-04-29
- 2025-07-29
- 2025-10-28
- 2026-01-12
- 2026-02-24
- 2026-04-28
- 2026-07-28
Trades before a print in Kiniksa Pharmaceuticals International, plc 11
- 0 days before the 2025-01-13 print — 2025-01-13 · S · Tessari Eben · 12,323 shares
- 0 days before the 2025-01-13 print — 2025-01-13 · S · Tessari Eben · 1,677 shares
- 0 days before the 2025-04-29 print — 2025-04-29 · S · Moat Ross · 64,035 shares
- 0 days before the 2025-04-29 print — 2025-04-29 · S · Ragosa Mark · 42,000 shares
- 0 days before the 2025-10-28 print — 2025-10-28 · S · Ragosa Mark · 100 shares
- 0 days before the 2026-04-28 print — 2026-04-28 · S · Patel Sanj K · 74,635 shares
- 0 days before the 2026-04-28 print — 2026-04-28 · S · Patel Sanj K · 113,673 shares
- 0 days before the 2026-04-28 print — 2026-04-28 · S · Patel Sanj K · 243,596 shares
- 0 days before the 2026-04-28 print — 2026-04-28 · S · Patel Sanj K · 51,750 shares
- 0 days before the 2026-04-28 print — 2026-04-28 · S · Quart Barry D · 13,099 shares
- 4 days before the 2026-01-12 print — 2026-01-08 · S · Ragosa Mark · 12,000 shares
- 6 days before the 2025-10-28 print — 2025-10-22 · S · Patel Sanj K · 97,390 shares
Interval to Kiniksa Pharmaceuticals International, plc’s next reported results date
How the interval and sources are counted →
- 11within 5 days
- 18within 10 days
- 0shortest, days
- 1no later print
- Tessari Eben 2025-01-13 · S · 0 days before the 2025-01-13 print · CHIEF OPERATING OFFICER
- Tessari Eben 2025-01-13 · S · 0 days before the 2025-01-13 print · CHIEF OPERATING OFFICER
- Moat Ross 2025-04-21 · S · 8 days before the 2025-04-29 print · CHIEF COMMERCIAL OFFICER
- Moat Ross 2025-04-29 · S · 0 days before the 2025-04-29 print · CHIEF COMMERCIAL OFFICER
- Ragosa Mark 2025-04-29 · S · 0 days before the 2025-04-29 print · CHIEF FINANCIAL OFFICER
- Megna Michael R 2025-10-20 · S · 8 days before the 2025-10-28 print · CHIEF ACCOUNTING OFFICER
- Megna Michael R 2025-10-20 · S · 8 days before the 2025-10-28 print · CHIEF ACCOUNTING OFFICER
- Patel Sanj K 2025-10-20 · S · 8 days before the 2025-10-28 print · CHAIRMAN & CEO
- Patel Sanj K 2025-10-20 · S · 8 days before the 2025-10-28 print · CHAIRMAN & CEO
- Patel Sanj K 2025-10-21 · S · 7 days before the 2025-10-28 print · CHAIRMAN & CEO
- Patel Sanj K 2025-10-22 · S · 6 days before the 2025-10-28 print · CHAIRMAN & CEO
- Ragosa Mark 2025-10-28 · S · 0 days before the 2025-10-28 print · CHIEF FINANCIAL OFFICER
- Ragosa Mark 2026-01-08 · S · 4 days before the 2026-01-12 print · CHIEF FINANCIAL OFFICER
- Patel Sanj K 2026-04-28 · S · 0 days before the 2026-04-28 print · CHAIRMAN & CEO
- Patel Sanj K 2026-04-28 · S · 0 days before the 2026-04-28 print · CHAIRMAN & CEO
- Patel Sanj K 2026-04-28 · S · 0 days before the 2026-04-28 print · CHAIRMAN & CEO
- Patel Sanj K 2026-04-28 · S · 0 days before the 2026-04-28 print · CHAIRMAN & CEO
- Quart Barry D 2026-04-28 · S · 0 days before the 2026-04-28 print
Reported results dates on file
- 2025-01-13
- 2025-02-25
- 2025-04-29
- 2025-07-29
- 2025-10-28
- 2026-01-12
- 2026-02-24
- 2026-04-28
- 2026-07-28
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.